Travere Therapeutics, Inc. TVTX

59.44 (1.18) (1.95%) as of 25 Sep
Market cap
$5.7B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
255.87 300.63 471.54 398.52 361.59 552.88 450.25 566.85 370.70 322.80
Receivables
18.51 13.87 12.66 19.44 33.07 15.91 16.65 21.18 27.12 80.13
Inventory
2.83 5.35 5.62 6.08 7.61 7.31 4.52 9.41 6.20 5.88
Total current assets
332.35 325.81 495.68 429.06 410.41 582.83 486.44 616.78 416.70 437.57
Property, Plant, Equpment (Net)
2.59 3.23 3.15 2.89 9.42 11.11 9.05 7.48 5.34 4.02
Long-Term Investments
— — 15.00 — — — — — — —
Goodwill and Intangible Assets (Total)
182.98 185.75 187.63 158.14 154.13 148.44 97.07 104.44 103.97 113.87
Long-term assets (Other)
7.36 5.56 7.71 14.71 7.81 11.07 10.68 42.16 53.82 39.16
Total non-current assets
192.93 194.54 213.48 175.74 197.03 193.81 186.15 172.14 177.42 167.63
Total Assets
525.28 520.35 709.16 604.80 607.44 776.63 672.59 788.91 594.13 605.19
Notes Payable
— — 22.46 — — — — — 68.68 —
Accounts Payable
7.52 18.94 6.95 26.61 12.13 15.14 17.29 41.68 23.53 24.80
Accrued Expenses
33.31 36.02 49.70 51.75 56.79 75.18 95.74 118.99 86.03 126.04
Current Revenue (Deferred)
— — — — — 16.27 11.98 7.10 2.82 —
Other current liabilities
42.43 30.71 25.52 17.09 23.38 13.59 5.72 5.24 17.11 3.19
Total current liabilities
83.26 85.67 104.62 95.45 92.66 124.09 142.16 177.91 200.75 159.90
Long Term Debt (Total)
44.42 45.08 195.09 204.86 215.34 226.58 375.55 377.26 310.31 311.72
Non-current Revenue (Deferred)
— — — — — 20.38 10.93 1.84 — —
Long Term Tax Liability (Deferred)
6.43 (6.42) — — — — — — — —
Non-current Liabilities (Other)
83.41 96.47 91.20 83.29 59.89 71.98 9.39 10.32 6.80 7.60
Total non-current liabilities
134.25 141.54 286.29 288.16 303.57 350.43 487.57 410.20 334.30 330.46
Total liabilities
217.52 227.21 390.91 383.60 396.23 474.52 629.73 588.10 535.05 490.36
Additional Paid In Capital
421.31 471.80 589.80 636.91 797.99 1,068.63 1,059.98 1,327.88 1,506.32 1,588.72
Common Stock (Net)
0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01
Retained Earnings
(113.06) (177.65) (270.02) (416.44) (585.87) (765.97) (1,014.22) (1,125.62) (1,447.17) (1,472.71)
Common Equity (Total)
307.77 293.13 318.25 221.20 211.21 302.11 42.85 200.81 59.08 114.83
Shareholders Equity (Total)
307.77 293.13 318.25 221.20 211.21 302.11 42.85 200.81 59.08 114.83
Shareholders Equity and Liabilities (Total)
525.28 520.35 709.16 604.80 607.44 776.63 672.59 788.91 594.13 605.19
Shares (Common)
37.91 39.37 41.39 43.09 52.25 62.49 64.29 75.37 87.45 90.92
Shareholders Equity (Tangible)
124.79 107.38 130.63 63.06 57.09 153.68 (54.22) 96.37 (44.90) 0.96
Net Debt
(211.45) (255.55) (276.45) (193.66) (146.25) (326.30) (74.70) (189.59) (60.39) (11.07)
Total Debt
44.42 45.08 195.09 204.86 215.34 226.58 375.55 377.26 310.31 311.72

Fold the line items

In millions of $ except per-share values · columns are period end dates